Stay updated on DARA/ATRA Combo in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.

Latest updates to the DARA/ATRA Combo in Myeloma: Clinical Trial page
- Check2 days agoChange Detected- The related topics section no longer includes 'Multiple myeloma' and 'MedlinePlus Genetics'.SummaryDifference0.6%

- Check9 days agoNo Change Detected
- Check23 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma, narrowing the page’s health topic coverage.SummaryDifference0.2%

- Check30 days agoChange Detected- Added a government funding lapse notice with status guidance and links; updated operating details for NIH Clinical Center. - Bumped revision from v3.1.0 to v3.2.0.SummaryDifference2%

- Check38 days agoChange DetectedUpdate term and version: replacing 'Plasma cell myeloma' with 'Multiple myeloma' and updating to revision v3.1.0.SummaryDifference0.1%

- Check52 days agoChange DetectedAdds MedlinePlus Genetics topic page on Multiple myeloma and updates to version v3.0.2; removes the old v3.0.1 tag and the Back to Top link.SummaryDifference0.3%

- Check59 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of multiple myeloma has been removed from the MedlinePlus Genetics section.SummaryDifference0.3%

Stay in the know with updates to DARA/ATRA Combo in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.